STOCK TITAN

Myers Inds Financials

MYE
FY2025 annual
Revenue $825.7M -1.3% YoY
Net Income $34.9M +385.0% YoY
EPS (Diluted) $0.93 +389.5% YoY
Free Cash Flow $67.2M +22.5% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Myers Inds (MYE) reported $825.7M in revenue for fiscal year 2025, down 1.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MYE FY2025

Debt-funded balance-sheet expansion briefly dented profit, but cash generation and working-capital discipline became the repair mechanism.

After the balance-sheet jump in FY2024, operating margin rebounded to 9.0% and free cash flow reached $67.2M even though revenue was slightly lower. That mix of better margins, lower inventory, and debt reduced to $311.2M suggests the 2024 earnings drop was more tied to financing and integration pressure than to a broken core cash engine.

The company’s cash conversion is stronger than net income alone implies: FY2025 operating cash flow was $86.8M versus net income of $34.9M, helped by a sharp reduction in inventory and receivables. That matters because a meaningful share of 2025 cash came from working-capital release, leaving room for dividends, a small buyback, and debt reduction.

Leverage is still the main structural constraint. Even after improvement, debt to equity remained above 1x while the current ratio stayed near 1.7x, so the pressure is more about long-term obligations than near-term liquidity. Capex of $19.6M against free cash flow of $67.2M also shows this is not a business where heavy reinvestment consumes most of the cash it generates.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 50 / 100
Financial Health Score 50/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Myers Inds's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
67

Myers Inds has an operating margin of 9.0%, meaning the company retains $9 of operating profit per $100 of revenue. This strong profitability earns a score of 67/100, reflecting efficient cost management and pricing power. This is up from 5.3% the prior year.

Growth
34

Myers Inds's revenue declined 1.3% year-over-year, from $836.3M to $825.7M. This contraction results in a growth score of 34/100.

Leverage
21

Myers Inds has elevated debt relative to equity (D/E of 1.06), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 21/100, reflecting increased financial risk.

Liquidity
47

Myers Inds's current ratio of 1.67 indicates adequate short-term liquidity, earning a score of 47/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
59

Myers Inds has a free cash flow margin of 8.1%, earning a moderate score of 59/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
70

Myers Inds earns a strong 11.9% return on equity (ROE), meaning it generates $12 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 70/100. This is up from 2.6% the prior year.

Altman Z-Score Grey Zone
2.72

Myers Inds scores 2.72, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
6/9

Myers Inds passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
2.48x

For every $1 of reported earnings, Myers Inds generates $2.48 in operating cash flow ($86.8M OCF vs $34.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$825.7M
YoY-1.3%
5Y CAGR+10.1%
10Y CAGR+3.8%

Myers Inds generated $825.7M in revenue in fiscal year 2025. This represents a decrease of 1.3% from the prior year.

EBITDA
$92.0M
YoY+47.1%
5Y CAGR+4.3%
10Y CAGR+3.2%

Myers Inds's EBITDA was $92.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 47.1% from the prior year.

Net Income
$34.9M
YoY+385.0%
5Y CAGR-1.0%
10Y CAGR+7.0%

Myers Inds reported $34.9M in net income in fiscal year 2025. This represents an increase of 385.0% from the prior year.

EPS (Diluted)
$0.93
YoY+389.5%
5Y CAGR-1.8%
10Y CAGR+5.0%

Myers Inds earned $0.93 per diluted share (EPS) in fiscal year 2025. This represents an increase of 389.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$67.2M
YoY+22.5%
5Y CAGR+15.2%
10Y CAGR+15.5%

Myers Inds generated $67.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 22.5% from the prior year.

Cash & Debt
$40.5M
YoY+25.7%
5Y CAGR+7.4%
10Y CAGR+32.9%

Myers Inds held $40.5M in cash against $311.2M in long-term debt as of fiscal year 2025.

Dividends Per Share
$0.54
YoY0.0%
5Y CAGR0.0%
10Y CAGR0.0%

Myers Inds paid $0.54 per share in dividends in fiscal year 2025. That is unchanged from the prior year.

Shares Outstanding
37M
YoY+0.3%
5Y CAGR+0.8%
10Y CAGR+2.4%

Myers Inds had 37M shares outstanding in fiscal year 2025. This represents an increase of 0.3% from the prior year.

Margins & Returns

Gross Margin
33.4%
YoY+1.1pp
5Y CAGR-0.3pp
10Y CAGR+2.6pp

Myers Inds's gross margin was 33.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.1 percentage points from the prior year.

Operating Margin
9.0%
YoY+3.7pp
5Y CAGR-1.5pp
10Y CAGR+3.0pp

Myers Inds's operating margin was 9.0% in fiscal year 2025, reflecting core business profitability. This is up 3.7 percentage points from the prior year.

Net Margin
4.2%
YoY+3.4pp
5Y CAGR-3.0pp
10Y CAGR+1.1pp

Myers Inds's net profit margin was 4.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 3.4 percentage points from the prior year.

Return on Equity
11.9%
YoY+9.3pp
5Y CAGR-7.6pp
10Y CAGR-6.3pp

Myers Inds's ROE was 11.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 9.3 percentage points from the prior year.

Capital Allocation

Share Buybacks
$2.5M

Myers Inds spent $2.5M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures
$19.6M
YoY-20.0%
5Y CAGR+7.8%
10Y CAGR-1.1%

Myers Inds invested $19.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 20.0% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

MYE Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MYE annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$844.6M$825.7M-1.3%$836.3M+2.9%$813.1M-9.6%$899.5M+18.1%$761.4M+49.2%$510.4M-1.0%$515.7M-9.0%$566.7M+3.6%$547.0M+2.4%$534.4M-6.4%$571.0M-8.4%$623.6M+6.7%$584.7M+7.2%$545.6M-27.8%$755.7M
Cost of Revenue$551.8M$549.7M-2.8%$565.5M+2.1%$554.0M-10.1%$616.2M+12.0%$550.0M+62.5%$338.4M-1.7%$344.4M-11.1%$387.4M-0.6%$389.6M+4.6%$372.5M-5.7%$395.2M-14.5%$462.4M+11.4%$415.2M+8.8%$381.7M-31.5%$557.4M
Gross Profit$292.8M$276.1M+1.9%$270.8M+4.5%$259.1M-8.6%$283.4M+34.0%$211.4M+22.9%$172.0M+0.4%$171.3M-4.5%$179.3M+13.9%$157.5M-2.7%$161.9M-7.9%$175.9M+9.0%$161.3M-4.9%$169.6M+3.5%$163.9M-17.3%$198.3M
SG&A Expenses$170.3M$172.4M-0.9%$174.0M+4.0%$167.3M-16.1%$199.5M+22.0%$163.5M+25.5%$130.3M-2.1%$133.1M+66.8%$79.8M+1.2%$78.9M+6.9%$73.8M-10.4%$82.3M+5.0%$78.4M+12.3%$69.8M+5.6%$66.1M-14.2%$77.1M
Operating Income$93.5M$74.6M+67.6%$44.5M-38.6%$72.4M-13.7%$83.9M+70.3%$49.3M-7.9%$53.5M+43.7%$37.3M+489.0%$6.3M-74.6%$24.9M-9.0%$27.4M-20.7%$34.5M+52.6%$22.6M-49.0%$44.3M-4.8%$46.5M+21.1%$38.4M
Interest ExpenseN/AN/AN/AN/AN/AN/A$4.9M+0.1%$4.9M-20.6%$6.2M-28.8%$8.7M-12.6%$9.9M-1.7%$10.1M+16.3%$8.7M+82.6%$4.7M+9.6%$4.3M-8.3%$4.7M
Income Tax$15.2M$10.2M+60.9%$6.3M-63.1%$17.2M-4.2%$17.9M+55.3%$11.6M-4.4%$12.1M+34.8%$9.0M+195.3%$3.0M-37.6%$4.9M-34.2%$7.4M-8.0%$8.0M+56.9%$5.1M-61.6%$13.3M-15.0%$15.7M+70.9%$9.2M
Net Income$36.6M$34.9M+385.0%$7.2M-85.3%$48.9M-18.9%$60.3M+79.7%$33.5M-8.8%$36.8M+51.1%$24.3M+826.6%-$3.3M+66.1%-$9.9M-1035.6%$1.1M-94.0%$17.8M+304.6%-$8.7M-133.4%$26.0M-13.2%$30.0M+22.3%$24.5M
EPS (Diluted)$0.93+389.5%$0.19-85.6%$1.32-19.5%$1.64+78.3%$0.92-9.8%$1.02+50.0%$0.68+780.0%-$0.10+69.7%-$0.33-1200.0%$0.03-94.7%$0.57+311.1%-$0.27-135.5%$0.76-13.6%$0.88+23.9%$0.71

Not reported in any period shown, so not listed: R&D Expenses.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

MYE Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MYE annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$852.6M-1.0%$860.8M+58.9%$541.6M-0.2%$542.6M+12.0%$484.5M+21.1%$400.0M+13.3%$353.1M+1.3%$348.6M-2.1%$355.9M-6.7%$381.7M-11.0%$429.0M-23.9%$563.4M+20.0%$469.5M-3.2%$484.9M+13.1%$428.8M
Current Assets$281.5M+8.5%$259.3M+1.0%$256.6M-0.2%$257.2M+17.0%$219.9M+19.7%$183.7M-0.7%$185.0M+1.2%$182.9M+21.9%$150.0M+6.3%$141.2M-8.5%$154.3M-45.9%$285.4M+21.5%$234.9M-2.0%$239.6M+9.7%$218.5M
Cash & Equivalents$40.5M+25.7%$32.2M+6.4%$30.3M+30.9%$23.1M+31.1%$17.7M-37.6%$28.3M-62.5%$75.5M+28.2%$58.9M+2237.1%$2.5M+4.8%$2.4M+2.2%$2.4M-36.0%$3.7M-43.8%$6.5M+65.6%$3.9M-41.9%$6.8M
Inventory$67.6M-30.4%$97.0M+6.8%$90.8M-2.7%$93.4M-0.2%$93.6M+41.9%$65.9M+48.9%$44.3M+1.5%$43.6M-7.3%$47.0M+5.0%$44.8M-18.2%$54.7M-13.6%$63.3M+19.2%$53.1M-50.6%$107.5M+12.9%$95.2M
Accounts Receivable$95.4M-12.7%$109.4M-4.0%$113.9M-9.7%$126.2M+25.3%$100.7M+20.3%$83.7M+34.4%$62.3M-14.6%$72.9M-4.8%$76.7M+19.2%$64.3M-17.2%$77.6M-14.4%$90.7M+21.0%$74.9M-35.1%$115.5M+9.1%$105.8M
Goodwill$241.3M-5.6%$255.5M+167.9%$95.4M+0.2%$95.2M+7.2%$88.8M+12.0%$79.3M+18.7%$66.8M+13.0%$59.1M-1.5%$60.0M+1.3%$59.2M+0.6%$58.9M-11.6%$66.6M+30.5%$51.1M-0.3%$51.2M+14.7%$44.7M
Total Liabilities$558.4M-4.3%$583.3M+134.4%$248.8M-13.1%$286.2M+4.0%$275.2M+30.5%$210.9M+13.1%$186.5M-3.9%$194.0M-26.0%$262.2M-9.2%$288.7M-12.9%$331.3M-20.5%$416.9M+78.2%$233.9M-8.2%$254.8M+14.5%$222.6M
Current Liabilities$169.0M+14.9%$147.1M-10.9%$165.1M+19.8%$137.8M+4.0%$132.5M-6.9%$142.2M+72.2%$82.6M-15.2%$97.4M-1.2%$98.7M+24.4%$79.3M-32.1%$116.8M-24.1%$153.8M+2.1%$150.6M+31.5%$114.5M+3.5%$110.7M
Long-Term Debt$311.2M-12.4%$355.3M+1010.7%$32.0M-66.0%$94.0M+3.3%$90.9M+142.0%$37.6M-51.3%$77.2M+0.5%$76.8M-49.2%$151.0M-20.3%$189.5M-1.2%$191.9M-18.8%$236.4M+433.1%$44.3M-52.2%$92.8M+25.9%$73.7M
Total Equity$294.2M+6.0%$277.5M-5.2%$292.8M+14.2%$256.4M+22.5%$209.3M+10.7%$189.1M+13.4%$166.7M+7.8%$154.6M+64.9%$93.8M+0.8%$93.0M-4.8%$97.7M-33.3%$146.6M-37.8%$235.5M+2.4%$230.0M+11.6%$206.1M
Retained Earnings-$33.9M+30.1%-$48.5M-36.4%-$35.5M+44.5%-$64.0M+38.6%-$104.2M+11.7%-$117.9M+12.7%-$135.1M+4.3%-$141.2M-18.1%-$119.5M-28.4%-$93.1M-19.6%-$77.8M+1.5%-$79.0M-47.6%-$53.5M+20.6%-$67.4M+22.1%-$86.5M

MYE Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

MYE annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$108.1M$86.8M+9.4%$79.3M-8.0%$86.2M+18.7%$72.6M+61.7%$44.9M-3.4%$46.5M-14.4%$54.3M-11.3%$61.3M+37.8%$44.5M+31.8%$33.7M-10.6%$37.7M-2.5%$38.7M-59.7%$96.1M+58.1%$60.8M-5.3%$64.2M
Capital Expenditures$16.3M$19.6M-20.0%$24.4M+6.9%$22.9M-5.9%$24.3M+36.0%$17.9M+33.1%$13.4M+30.4%$10.3M+100.9%$5.1M-11.9%$5.8M-53.4%$12.5M-42.7%$21.8M-9.9%$24.2M+16.7%$20.7M+4.3%$19.9M-9.4%$21.9M
Free Cash Flow$91.7M$67.2M+22.5%$54.9M-13.4%$63.3M+31.0%$48.3M+78.7%$27.0M-18.3%$33.1M-24.9%$44.0M-21.6%$56.1M+45.2%$38.6M+82.0%$21.2M+33.2%$15.9M+9.8%$14.5M-80.7%$75.4M+84.3%$40.9M-3.2%$42.2M
Investing Cash Flow-$14.5M-$18.9M+94.9%-$372.5M-1536.9%-$22.8M+54.8%-$50.4M-0.2%-$50.3M+33.4%-$75.6M-264.0%-$20.8M-733.6%-$2.5M-160.2%$4.1M+125.7%-$16.1M-133.7%$47.7M+128.3%-$168.6M-463.1%-$29.9M+29.5%-$42.5M-92.8%-$22.0M
Financing Cash Flow-$82.7M-$54.5M-118.5%$295.1M+622.1%-$56.5M-246.4%-$16.3M-214.5%-$5.2M+71.7%-$18.3M-7.8%-$17.0M-57.9%-$10.8M+80.0%-$53.7M-202.7%-$17.8M+78.3%-$81.8M-164.5%$126.9M+308.7%-$60.8M-154.4%-$23.9M+39.4%-$39.4M
Dividends Paid$20.4M$20.5M+0.3%$20.4M+0.9%$20.2M+2.2%$19.8M+1.0%$19.6M+0.9%$19.4M+0.6%$19.3M+8.1%$17.9M+9.3%$16.3M+0.7%$16.2M-2.7%$16.7M+6.2%$15.7M+72.5%$9.1M-30.0%$13.0M+36.6%$9.5M
Share Buybacks$1.0M$2.5M$0$0N/AN/AN/AN/AN/A$0$0-100.0%$30.0M-45.3%$54.9M+578.1%$8.1M+92.6%$4.2M-79.9%$20.9M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

MYE Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

MYE annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin33.4%+1.1pp32.4%+0.5pp31.9%+0.4pp31.5%+3.7pp27.8%-5.9pp33.7%+0.5pp33.2%+1.6pp31.6%+2.9pp28.8%-1.5pp30.3%-0.5pp30.8%+4.9pp25.9%-3.1pp29.0%-1.0pp30.0%+3.8pp26.2%
Operating Margin9.0%+3.7pp5.3%-3.6pp8.9%-0.4pp9.3%+2.9pp6.5%-4.0pp10.5%+3.3pp7.2%+6.1pp1.1%-3.4pp4.5%-0.6pp5.1%-0.9pp6.0%+2.4pp3.6%-4.0pp7.6%-0.9pp8.5%+3.5pp5.1%
Net Margin4.2%+3.4pp0.9%-5.2pp6.0%-0.7pp6.7%+2.3pp4.4%-2.8pp7.2%+2.5pp4.7%+5.3pp-0.6%+1.2pp-1.8%-2.0pp0.2%-2.9pp3.1%+4.5pp-1.4%-5.8pp4.5%-1.0pp5.5%+2.3pp3.2%
Return on Equity11.9%+9.3pp2.6%-14.1pp16.7%-6.8pp23.5%+7.5pp16.0%-3.4pp19.4%+4.8pp14.6%+16.8pp-2.2%+8.4pp-10.5%-11.7pp1.1%-17.0pp18.2%+24.1pp-5.9%-17.0pp11.0%-2.0pp13.0%+1.1pp11.9%
Return on Assets4.1%+3.3pp0.8%-8.2pp9.0%-2.1pp11.1%+4.2pp6.9%-2.3pp9.2%+2.3pp6.9%+7.8pp-1.0%+1.8pp-2.8%-3.1pp0.3%-3.9pp4.1%+5.7pp-1.5%-7.1pp5.5%-0.6pp6.2%+0.5pp5.7%
Current Ratio1.67-0.1x1.76+0.2x1.55-0.3x1.87+0.2x1.66+0.4x1.29-0.9x2.24+0.4x1.88+0.4x1.52-0.3x1.78+0.5x1.32-0.5x1.86+0.3x1.56-0.5x2.09+0.1x1.97
Debt-to-Equity1.06-0.2x1.28+1.2x0.11-0.3x0.37-0.1x0.43+0.2x0.20-0.3x0.460.0x0.50-1.1x1.61-0.4x2.04+0.1x1.96+0.4x1.61+1.4x0.19-0.2x0.400.0x0.36
FCF Margin8.1%+1.6pp6.6%-1.2pp7.8%+2.4pp5.4%+1.8pp3.5%-2.9pp6.5%-2.1pp8.5%-1.4pp9.9%+2.8pp7.1%+3.1pp4.0%+1.2pp2.8%+0.5pp2.3%-10.6pp12.9%+5.4pp7.5%+1.9pp5.6%

Similar Companies

Frequently Asked Questions

What is Myers Inds's annual revenue?

Myers Inds (MYE) reported $825.7M in total revenue for fiscal year 2025. This represents a -1.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Myers Inds's revenue growing?

Myers Inds (MYE) revenue declined by 1.3% year-over-year, from $836.3M to $825.7M in fiscal year 2025.

Is Myers Inds profitable?

Yes, Myers Inds (MYE) reported a net income of $34.9M in fiscal year 2025, with a net profit margin of 4.2%.

Myers Inds (MYE) reported diluted earnings per share of $0.93 for fiscal year 2025. This represents a 389.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Myers Inds (MYE) had EBITDA of $92.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Myers Inds (MYE) had $40.5M in cash and equivalents against $311.2M in long-term debt.

Myers Inds (MYE) had a gross margin of 33.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Myers Inds (MYE) had an operating margin of 9.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Myers Inds (MYE) had a net profit margin of 4.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Myers Inds (MYE) paid $0.54 per share in dividends during fiscal year 2025.

Myers Inds (MYE) has a return on equity of 11.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Myers Inds (MYE) generated $67.2M in free cash flow during fiscal year 2025. This represents a 22.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Myers Inds (MYE) generated $86.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Myers Inds (MYE) had $852.6M in total assets as of fiscal year 2025, including both current and long-term assets.

Myers Inds (MYE) invested $19.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Myers Inds (MYE) spent $2.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Myers Inds (MYE) had 37M shares outstanding as of fiscal year 2025.

Myers Inds (MYE) had a current ratio of 1.67 as of fiscal year 2025, which is generally considered healthy.

Myers Inds (MYE) had a debt-to-equity ratio of 1.06 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Myers Inds (MYE) had a return on assets of 4.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Myers Inds (MYE) has an Altman Z-Score of 2.72, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Myers Inds (MYE) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Myers Inds (MYE) has an earnings quality ratio of 2.48x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Myers Inds (MYE) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top